Dysregulated inflammation as a risk factor for pneumonia in the elderly

Aging and Disease

Volumn 2, Issue 6, 2011, Pages 487-500

  Boyd, Angela R ^a   Orihuela, Carlos J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; Inflammation; Pneumonia; Statins; Toll like receptors

Indexed keywords

EID: 84861727490     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Janssens JP (2005). Pneumonia in the elderly (geriatric) population. Curr Opin Pulm Med, 11: 226-230
2. Vincent GKaVAV (2010). THE NEXT FOUR DECADES, The Older Population in the United States: 2010 to 2050, Current Population Reports. U.S. Census Bureau, Washington, DC.: P25-1138
3. Meyer KC, Rosenthal NS, Soergel P and Peterson K (1998). Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev, 104: 169-181
4. Loeb M (2004). Pneumonia in the elderly. Curr Opin Infect Dis, 17: 127-130
5. Janssens JP and Krause KH (2004). Pneumonia in the very old. Lancet Infect Dis, 4: 112-124
6. Chong CP and Street PR (2008). Pneumonia in the elderly: a review of the epidemiology, pathogenesis, microbiology, and clinical features. South Med J, 101: 1141-1145; quiz 1132, 1179
7. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R and Linde-Zwirble WT (2002). Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med, 165: 766-772
8. Torres OH, Munoz J, Ruiz D, Ris J, Gich I, Coma E, Gurgui M and Vazquez G (2004). Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc, 52: 1603-1609
9. Bohannon RW and Maljanian RD (2003). Hospital readmissions of elderly patients hospitalized with pneumonia. Conn Med, 67: 599-603
10. Perry TW, Pugh MJ, Waterer GW, Nakashima B, Orihuela CJ, Copeland LA, Restrepo MI, Anzueto A and Mortensen EM (2011). Incidence of cardiovascular events after hospital admission for pneumonia. Am J Med, 124: 244-251
11. Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, Weber JR, Murray PJ and Tuomanen EI (2006). Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol, 177: 6182-6191
12. Koivula I, Sten M and Makela PH (1994). Risk factors for pneumonia in the elderly. Am J Med, 96: 313-320
13. Meyer KC, Ershler W, Rosenthal NS, Lu XG and Peterson K (1996). Immune dysregulation in the aging human lung. Am J Respir Crit Care Med, 153: 1072-1079
14. Rimland D and Moanna A (2010). Increasing incidence of herpes zoster among Veterans. Clin Infect Dis, 50: 1000-1005
15. Sambhara S and McElhaney JE (2009). Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol, 333: 413-429
16. McElhaney JE and Effros RB (2009). Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol, 21: 418-424
17. MG Thompson P, DK Shay, MD, H Zhou, MSc, MPH, CB Bridges, MD, PY Cheng, PhD, E Burns, MA, JS Bresee, MD, NJ Cox, PhD (2010). Estimates of Deaths Associated with Seasonal Influenza --- United States, 1976--2007. Morbidity and Mortality Weekly Report (MMWR), 59:1057-1062
18. Mandell LA, Bartlett JG, Dowell SF, File TM, Jr., Musher DM and Whitney C (2003). Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis, 37: 1405-1433
19. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A and Whitney CG (2001). Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Jama, 285: 1729-1735
20. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR and Whitney CG (2005). Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Jama, 294: 2043-2051
21. Atkinson W, Hamborsky J, McIntyre L and Wolfe S (2007) Pneumococcal Disease. In Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. , Public Health Foundation, Washington DC
22. (1999). Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec, 74: 177-183
23. Lynch JP, 3rd and Zhanel GG (2010). Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med, 16: 217-225
24. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH and Schuchat A (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med, 348: 1737-1746
25. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK and Thompson WW (2003). Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med, 348: 1747-1755
26. Weng NP (2006). Aging of the immune system: how much can the adaptive immune system adapt? Immunity, 24: 495-499
27. Rubins JB, Puri AK, Loch J, Charboneau D, MacDonald R, Opstad N and Janoff EN (1998). Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis, 178: 431-440
28. Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD and Carlone GM (1999). Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis, 29: 281-288
29. Bruunsgaard H, Pedersen M and Pedersen BK (2001). Aging and proinflammatory cytokines. Curr Opin Hematol, 8: 131-136
30. Ershler WB (1993). Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc, 41: 176-181
31. Sarkar D and Fisher PB (2005). Molecular mechanisms of aging-associated inflammation. Cancer Lett
32. Krabbe KS, Pedersen M and Bruunsgaard H (2004). Inflammatory mediators in the elderly. Exp Gerontol, 39: 687-699
33. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E and De Benedictis G (2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci, 908: 244-254
34. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R and Havlik RJ (1999). Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc, 47: 639-646
35. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr., Heimovitz H, Cohen HJ and Wallace R (1999). Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med, 106: 506-512
36. Hager K, Machein U, Krieger S, Platt D, Seefried G and Bauer J (1994). Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging, 15: 771-772
37. Spencer NF, Poynter ME, Im SY and Daynes RA (1997). Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol, 9: 1581-1588
38. Yende S, Tuomanen EI, Wunderink R, Kanaya A, Newman AB, Harris T, de Rekeneire N and Kritchevsky SB (2005). Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med, 172: 1440-1446
39. Antunes G, Evans SA, Lordan JL and Frew AJ (2002). Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J, 20: 990-995
40. Glynn P, Coakley R, Kilgallen I, Murphy N and O'Neill S (1999). Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax, 54: 51-55
41. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M and Tuomanen E (2000). The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell, 102: 827-837
42. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I and Tuomanen EI (1995). Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature, 377: 435-438
43. Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ and Tuomanen E (2004). B-arrestin 1 determines the traffic pattern of PAFr-mediated enodocytosis of Streptococcus pneumoniae.
44. Kaetzel CS (2001). Polymeric Ig receptor: defender of the fort or Trojan horse? Curr Biol, 11: R35-38
45. Elm C, Braathen R, Bergmann S, Frank R, Vaerman JP, Kaetzel CS, Chhatwal GS, Johansen FE and Hammerschmidt S (2004). Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem, 279: 6296-6304
46. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, Oldfield NJ, Self T, Ala'Aldeen DA and Tuomanen EI (2009). Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest, 119: 1638-1646
47. Shivshankar P, Boyd AR, Le Saux CJ, Yeh IT and Orihuela CJ (2011). Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell
48. Hinojosa E, Boyd AR and Orihuela CJ (2009). Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis, 200: 546-554
49. Weiser JN, Goldberg JB, Pan N, Wilson L and Virji M (1998). The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun, 66: 4263-4267
50. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, Weiser JN, Gibson BW and Apicella MA (2000). Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol, 37: 13-27
51. Bruunsgaard H, Skinhoj P, Qvist J and Pedersen BK (1999). Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis, 180: 551-554
52. Arai Y, Takayama M, Abe Y and Hirose N (2011). Adipokines and Aging. J Atheroscler Thromb
53. Meijer RI, Serne EH, Smulders YM, van Hinsbergh VW, Yudkin JS and Eringa EC (2011). Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep, 11: 211-217
54. Mathur SK, Jain P and Mathur P (2011). Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications. J Obes, 2011: 587495
55. Dasu MR and Jialal I (2011). Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab, 300: E145-154
56. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL and Weiser JN (2006). Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem, 281: 12994-12998
57. Bartlett JA, Fischer AJ and McCray PB, Jr. (2008). Innate immune functions of the airway epithelium. Contrib Microbiol, 15: 147-163
58. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD and Millar AB (2004). Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol, 31: 241-245
59. Ha U, Lim JH, Jono H, Koga T, Srivastava A, Malley R, Pages G, Pouyssegur J and Li JD (2007). A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol, 178: 1736-1747
60. Kreiling JA, Tamamori-Adachi M, Sexton AN, Jeyapalan JC, Munoz-Najar U, Peterson AL, Manivannan J, Rogers ES, Pchelintsev NA, Adams PD and Sedivy JM Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell, 10: 292-304
61. Campisi J and D'Adda di Fagagna F (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol, 8: 729-740
62. Aoshiba K and Nagai A (2009). Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 6: 596-601
63. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY and Campisi J (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol, 6: 2853-2868
64. Shivshankar P, Sanchez C, Rose LF and Orihuela CJ (2009). The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Mol Microbiol, 73: 663-679
65. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M and Lowry SF (1997). Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis, 176: 439-444
66. van der Poll T, Keogh CV, Buurman WA and Lowry SF (1997). Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med, 155: 603-608
67. Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M and Yamaguchi K (1997). Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun, 65: 257-260
68. Kawai T and Akira S (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11: 373-384
69. Takeda K, Kaisho T and Akira S (2003). Toll-like receptors. Annu Rev Immunol, 21: 335-376
70. Knapp S, Wieland CW, van 't Veer C, Takeuchi O, Akira S, Florquin S and van der Poll T (2004). Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol, 172: 3132-3138
71. Dessing MC, Schouten M, Draing C, Levi M, von Aulock S and van der Poll T (2008). Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J Infect Dis, 197: 245-252
72. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR and Golenbock DT (2003). Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection. Proceedings of the National Academy of Sciences of the United States of America, 100: 1966-1971
73. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S and Henriques-Normark B (2007). Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol, 9: 633-644
74. Chapman SJ (2010). Can your genes make you more prone to pneumococcal disease? Expert Rev Anti Infect Ther, 8: 967-972
75. Saito T, Yamamoto T, Kazawa T, Gejyo H and Naito M (2005). Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse. Cell Tissue Res, 321: 75-88
76. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K and Horie T (1996). Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol, 106: 120-126
77. Ito Y, Betsuyaku T, Moriyama C, Nasuhara Y and Nishimura M (2009). Aging affects lipopolysaccharide-induced upregulation of heme oxygenase-1 in the lungs and alveolar macrophages. Biogerontology, 10: 173-180
78. Murciano C, Yanez A, O'Connor JE, Gozalbo D and Gil ML (2008). Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol Med Microbiol, 53: 214-221
79. Esposito AL, Clark CA and Poirier WJ (1988). An assessment of the respiratory burst and bactericidal activity of alveolar macrophages from adult and senescent mice. J Leukoc Biol, 43: 445-454
80. van Duin D and Shaw AC (2007). Toll-like receptors in older adults. J Am Geriatr Soc, 55: 1438-1444
81. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, Allore HG, Medzhitov R and Shaw AC (2007). Age-associated defect in human TLR-1/2 function. J Immunol, 178: 970-975
82. Nyugen J, Agrawal S, Gollapudi S and Gupta S (2010). Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol, 30: 806-813
83. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE and Dinarello CA (1998). Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci, 53: M20-26
84. Gabriel P, Cakman I and Rink L (2002). Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol, 37: 235-247
85. Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, Wagner T and Fehm HL (1995). Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev, 84: 113-126
86. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R and Carracedo J (2011). Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol, 186: 1809-1815
87. Ziegler-Heitbrock L (2007). The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol, 81: 584-592
88. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J and Sambhara S (2002). Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol, 169: 4697-4701
89. Boehmer ED, Goral J, Faunce DE and Kovacs EJ (2004). Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol, 75: 342-349
90. Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ and Bondada S (2006). Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol, 79: 1314-1327
91. Stout RD and Suttles J (2004). Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol, 76: 509-513
92. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK and Suttles J (2005). Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol, 175: 342-349
93. Rottinghaus EK, Vesosky B and Turner J (2010). TLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice. Mech Ageing Dev, 131: 405-414
94. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR and Shaw AC (2010). Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol, 184: 2518-2527
95. Stout-Delgado HW, Yang X, Walker WE, Tesar BM and Goldstein DR (2008). Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J Immunol, 181: 6747-6756
96. Xiong Y, Qiu F, Piao W, Song C, Wahl LM and Medvedev AE (2011). Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem, 286: 7905-7916
97. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, Lawrence T, van Rijt LS, Lambrecht BN, Sirard JC and Hussell T (2008). Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med, 205: 323-329
98. Krabbe KS, Bruunsgaard H, Hansen CM, Moller K, Fonsmark L, Qvist J, Madsen PL, Kronborg G, Andersen HO, Skinhoj P and Pedersen BK (2001). Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol, 8: 333-338
99. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A and Cross AJ (2011). Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort. Am J Gastroenterol
100. Voiriot G, Dury S, Parrot A, Mayaud C and Fartoukh M (2011). Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest, 139: 387-394
101. van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM and Leufkens HG (2006). Statin therapy and reduced risk of pneumonia in patients with diabetes. Thorax
102. Mortensen EM, Restrepo MI, Anzueto A and Pugh J (2005). The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res, 6: 82
103. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L and Danon A (2004). Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation, 110: 880-885
104. Rosch JW, Boyd AR, Hinojosa E, Pestina T, Hu Y, Persons DA, Orihuela CJ and Tuomanen EI (2010). Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. J Clin Invest, 120: 627-635
105. Overturf GD (1999). Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis, 14: 191-218
106. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL and Strong R Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice. J Gerontol A Biol Sci Med Sci
107. Methe H, Kim JO, Kofler S, Nabauer M and Weis M (2005). Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol, 25: 1439-1445
108. Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS and McAuley DF (2009). Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med, 179: 1107-1114
109. Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D and Almog Y (2009). The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med, 35: 1255-1260
110. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA and Worthen GS (2005). A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med, 171: 606-615
111. Benati D, Ferro M, Savino MT, Ulivieri C, Schiavo E, Nuccitelli A, Pasini FL and Baldari CT (2009). Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus. J Leukoc Biol, 87: 433-442
112. Chow OA, von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK and Nizet V (2010). Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe, 8: 445-454